Form 8-K - Current report:
SEC Accession No. 0000950123-10-050815
Filing Date
2010-05-18
Accepted
2010-05-18 16:00:43
Documents
2
Period of Report
2010-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y03529e8vk.htm 8-K 10533
2 EX-99.1 y03529exv99w1.htm EX-99.1 10756
  Complete submission text file 0000950123-10-050815.txt   23029
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 10842566
SIC: 2836 Biological Products, (No Diagnostic Substances)